Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.09 |
Long Term Debt-Equity Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
Current Ratio | 3.60 | 3.73 | 3.18 | 2.98 | 2.44 |
Fixed Assets | 2.16 | 2.11 | 2.28 | 2.29 | 1.84 |
Inventory | 5.30 | 5.58 | 6.67 | 7.13 | 5.98 |
Debtors | 2.53 | 2.37 | 3.17 | 3.62 | 2.55 |
Interest Cover Ratio | 174.63 | 37.58 | 36.40 | 24.24 | 8.23 |
PBIDTM (%) | 23.67 | 23.26 | 23.69 | 24.16 | 16.53 |
PBITM (%) | 20.26 | 20.70 | 21.01 | 21.63 | 13.85 |
PBDTM (%) | 23.56 | 22.71 | 23.12 | 23.27 | 14.85 |
CPM (%) | 19.09 | 18.26 | 18.48 | 18.94 | 11.43 |
APATM (%) | 15.68 | 15.70 | 15.80 | 16.41 | 8.74 |
ROCE (%) | 14.67 | 14.11 | 19.45 | 22.04 | 10.19 |
RONW (%) | 11.46 | 10.85 | 15.02 | 17.29 | 7.07 |